NATIONAL ORGANIZATION FOR RARE DISORDERS, INC. (NORD) for NATIONAL ORGANIZATION FOR RARE DISORDERS INC (NORD)
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Pharmaceutical issues impacting patients with rare diseases. Drug Pricing and Orphan Drug Act. Accelerated Approval Pathway. Orphan Drug Tax Credit. H.R.1629 - Fairness in Orphan Drug Exclusivity Act. Cures 2.0.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CORINNE ALBERTS | — |
| ROSE AVELLINO GALLAGHER | — |
| HEIDI ROSS | — |
| RICHARD WHITE | — |
Health Issues HCR
Health issues impacting patients with rare diseases. Rare disease initiatives. Telehealth. Step Therapy. User Fee Negotiations. Newborn screening. Affordable Care Act (ACA) issues. Affordable Care Act (ACA) enhancements. COVID-19 Related Issues. Medical Nutrition. Paid Medical and Family Leave
| Lobbyist | Covered position, as disclosed |
|---|---|
| CORINNE ALBERTS | — |
| ROSE AVELLINO GALLAGHER | — |
| HEIDI ROSS | — |
| RICHARD WHITE | — |
Medicare/Medicaid MMM
Medicare / Medicaid issues impacting patients with rare diseases. Medicare Part D Program. Prescription Drug Pricing. Accelerated Approval. Medicare issues related to medical nutrition.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROSE AVELLINO GALLAGHER | — |
| HEIDI ROSS | — |
Budget/Appropriations BUD
Public Health Agency Appropriations.
| Lobbyist | Covered position, as disclosed |
|---|---|
| RICHARD WHITE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.